Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Current Liabilities (2018 - 2025)

Dna X filings provide 8 years of Total Current Liabilities readings, the most recent being $48.0 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 9.8% to $48.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.0 million, a 9.8% increase, with the full-year FY2025 number at $48.0 million, up 9.8% from a year prior.
  • Total Current Liabilities hit $48.0 million in Q4 2025 for Dna X, up from $38.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $48.0 million in Q4 2025 to a low of $19.9 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $30.2 million (2023), compared with a mean of $30.4 million.
  • Biggest five-year swings in Total Current Liabilities: dropped 29.33% in 2024 and later skyrocketed 65.33% in 2025.
  • Dna X's Total Current Liabilities stood at $21.0 million in 2021, then surged by 52.79% to $32.1 million in 2022, then rose by 0.27% to $32.1 million in 2023, then soared by 36.06% to $43.7 million in 2024, then grew by 9.8% to $48.0 million in 2025.
  • The last three reported values for Total Current Liabilities were $48.0 million (Q4 2025), $38.9 million (Q3 2025), and $35.7 million (Q2 2025) per Business Quant data.